News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Myeloma Paper of the Day, March 11th, suggested by Robert Orlowski
Mar 11, 2025, 09:16

Myeloma Paper of the Day, March 11th, suggested by Robert Orlowski

Robert Orlowski, Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:

“Myeloma Paper of the Day: Phase II of zanubrutinib + ixazomib/dex in newly diagnosed Waldenström macroglobulinemia finds 4.2% CR and 41.6% VGPR rates; overall, major and deep remission rates 100%, 95.8% and 45.8%; median PFS and OS 40 mos and not reached.”

“Zanubrutinib plus Ixazomib and Dexamethasone in newly diagnosed symptomatic Waldenström macroglobulinemia:a phase II study”

Authors: Wenjie Xiong, Yuting Yan, Tingyu Wang, Lugui Qiu, Shuhua Yi et al.

Myeloma Paper of the Day, March 11th, suggested by Robert Orlowski

More posts featuring Robert Orlowski.

cancer ixazomib Lugui Qiu Myeloma Paper of the Day OncoDaily Oncology Robert Orlowski Shuhua Yi Tingyu Wang Waldenström macroglobulinemia Wenjie Xiong Yuting Yan Zanubrutinib
Special Coverage
Blog
Aug 6, 2025, 07:42
Luis Moreno Sánchez: Comparison of Hypofractionation and Conventional Fractionation in Postmastectomy Radiotherapy
Insight
Aug 6, 2025, 07:04
A New Article on Colorectal Cancer on OncoDaily Medical Journal
Science
Aug 6, 2025, 07:02
Konstantina Stylianou: How Evidence-based Integrative Oncology Can Impact Young Adults Facing Aggressive Cancers
Science
Aug 6, 2025, 06:42
Diego Díaz-García: A Promising Shift in Neuro-Oncology Strategies
Science
Aug 6, 2025, 06:33
Bishal Gyawali: How to Improve the Success Rates of Phase 3 Oncology Trials
Blog
Aug 6, 2025, 06:26
Patrick Hwu: The Gonzmart Family's Commitment to Advancing Cancer Research
Insight
Aug 6, 2025, 06:21
Tian Zhang: Great Editorial Led by Nicolas Sayegh on Subsets of Prostate Cancer
Blog
Aug 6, 2025, 06:20
From an Unexpected Diagnosis to Adjusting to Long-Term Care - European Cancer Organisation
Blog
Aug 6, 2025, 06:11
Nelson Dusetti: The Complex Interactions Between Neoplastic Cells and the Tumor Microenvironment
Blog
Aug 6, 2025, 05:59
Yoel Bakas: Pancreatic Cancer Machine Learning Research Shows Promise
Blog
Aug 6, 2025, 05:45
Fabio Ynoe de Moraes: A Congress That Showcased the Power of Science and Human Connections
Insight
Aug 6, 2025, 05:45
Neeraj Agarwal: Striking Results in JCO from Ph2b SunRISe-1 Trial